Aquestive Therapeutics, Inc. Class Action Lawsuit
Company: Aquestive Therapeutics, Inc.
Ticker: (NASDAQ) AQST
Class Action Period: June 16, 2025 - January 8, 2026
See If You Qualify For Monetary Reward
Join the Aquestive Therapeutics, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
June 16, 2025 - January 8, 2026
Allegations
According to the complaint, defendants provided investors with positive statements while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Aquestive’s New Drug Application (NDA) for Anaphylm (Dibutepinephrine) sublingual film; pertinently, Aquestive concealed or otherwise minimized the significance of the human factors involved in the use and deployment of its sublingual film, such as packaging, use, administration, and labeling. On January 9, 2026, Aquestive announced that the Company was in receipt of a letter from the FDA identifying deficiencies that precluded labeling discussions for Anaphylm. Moreover, Aquestive revealed that the letter from the FDA confirmed that the Agency’s review of Anaphylm NDA was ongoing and no final decision had been made, which effectively delayed the approval of Anaphylm well beyond the January 31, 2026 Prescription Drug User Fee Act date. Following this news, the price of Aquestive’s common stock declined dramatically. From a closing market price of $6.21 per share on January 8, 2026, Aquestive’s stock price fell to $3.91 per share on January 9, 2026, a decline of over 37% in a single day.
Eligibility
To join the lawsuit, you must have experienced a loss on Aquestive shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Aquestive Therapeutics, Inc. during the relevant time frame, you have until May 4, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
EXPLORE MORE CASES
Paysafe Limited
PSFE
Lead Plaintiff Deadline: April 7, 2026
Class Period: March 4, 2025 - November 12, 2025
PayPal Holdings, Inc.
PYPL
Lead Plaintiff Deadline: April 20, 2026
Class Period: February 25, 2025 - February 2, 2026